Annual EBIT
-$5.75 M
+$780.87 K+11.95%
31 August 2024
Summary:
Lexaria Bioscience annual earnings before interest & taxes is currently -$5.75 million, with the most recent change of +$780.87 thousand (+11.95%) on 31 August 2024. During the last 3 years, it has fallen by -$66.23 thousand (-1.16%). LEXX annual EBIT is now -41289.42% below its all-time high of $442.70 thousand.LEXX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$2.20 M
-$460.16 K-26.40%
31 August 2024
Summary:
Lexaria Bioscience quarterly earnings before interest & taxes is currently -$2.20 million, with the most recent change of -$460.16 thousand (-26.40%) on 31 August 2024. Over the past year, it has dropped by -$1.06 million (-93.40%). LEXX quarterly EBIT is now -409.59% below its all-time high of $711.60 thousand, reached on 31 October 2007.LEXX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$5.74 M
-$1.09 M-23.42%
31 August 2024
Summary:
Lexaria Bioscience TTM earnings before interest & taxes is currently -$5.74 million, with the most recent change of -$1.09 million (-23.42%) on 31 August 2024. Over the past year, it has increased by +$239.94 thousand (+4.01%). LEXX TTM EBIT is now -1188.14% below its all-time high of $527.30 thousand, reached on 31 July 2008.LEXX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LEXX EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.9% | -93.4% | +4.0% |
| 3 y3 years | -1.2% | -10.0% | +17.8% |
| 5 y5 years | -41.7% | -135.8% | -33.4% |
LEXX EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1.2% | +13.1% | -237.5% | +8.9% | -23.4% | +21.6% |
| 5 y | 5 years | -41.7% | +13.1% | -237.5% | +14.2% | -41.3% | +21.6% |
| alltime | all time | <-9999.0% | +13.1% | -409.6% | +35.6% | -1188.1% | +21.6% |
Lexaria Bioscience EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Aug 2024 | -$5.75 M(-12.0%) | -$2.20 M(+26.4%) | -$5.74 M(+23.4%) |
| May 2024 | - | -$1.74 M(+167.0%) | -$4.65 M(-12.4%) |
| Feb 2024 | - | -$652.70 K(-42.7%) | -$5.31 M(-11.2%) |
| Nov 2023 | - | -$1.14 M(+2.2%) | -$5.98 M(-8.5%) |
| Aug 2023 | -$6.53 M(-1.3%) | -$1.11 M(-53.6%) | -$6.53 M(+5.9%) |
| May 2023 | - | -$2.40 M(+81.4%) | -$6.17 M(-0.3%) |
| Feb 2023 | - | -$1.32 M(-21.9%) | -$6.19 M(-2.0%) |
| Nov 2022 | - | -$1.70 M(+126.5%) | -$6.31 M(-4.7%) |
| Aug 2022 | -$6.62 M(+16.4%) | -$748.50 K(-69.0%) | -$6.62 M(-7.7%) |
| May 2022 | - | -$2.42 M(+66.9%) | -$7.17 M(-2.0%) |
| Feb 2022 | - | -$1.45 M(-27.7%) | -$7.32 M(+4.9%) |
| Nov 2021 | - | -$2.00 M(+53.8%) | -$6.98 M(+22.7%) |
| Aug 2021 | -$5.69 M(+37.1%) | -$1.30 M(-49.2%) | -$5.69 M(+6.9%) |
| May 2021 | - | -$2.57 M(+132.4%) | -$5.32 M(+28.8%) |
| Feb 2021 | - | -$1.10 M(+54.9%) | -$4.13 M(+1.0%) |
| Nov 2020 | - | -$713.10 K(-23.7%) | -$4.09 M(-5.1%) |
| Aug 2020 | -$4.15 M(+2.2%) | -$935.10 K(-32.2%) | -$4.31 M(-2.0%) |
| May 2020 | - | -$1.38 M(+29.7%) | -$4.40 M(+4.4%) |
| Feb 2020 | - | -$1.06 M(+13.7%) | -$4.21 M(-2.1%) |
| Nov 2019 | - | -$934.50 K(-8.7%) | -$4.30 M(+6.0%) |
| Aug 2019 | -$4.06 M(-38.5%) | -$1.02 M(-14.1%) | -$4.06 M(-4.8%) |
| May 2019 | - | -$1.19 M(+3.3%) | -$4.26 M(-34.3%) |
| Feb 2019 | - | -$1.15 M(+66.7%) | -$6.49 M(-3.3%) |
| Nov 2018 | - | -$691.80 K(-43.6%) | -$6.72 M(+1.8%) |
| Aug 2018 | -$6.60 M(+243.1%) | -$1.23 M(-64.1%) | -$6.60 M(+8.3%) |
| May 2018 | - | -$3.42 M(+148.5%) | -$6.09 M(+102.2%) |
| Feb 2018 | - | -$1.38 M(+139.4%) | -$3.01 M(+43.5%) |
| Nov 2017 | - | -$575.20 K(-20.0%) | -$2.10 M(+9.2%) |
| Aug 2017 | -$1.92 M(+50.9%) | -$718.70 K(+109.8%) | -$1.92 M(+25.7%) |
| May 2017 | - | -$342.50 K(-26.0%) | -$1.53 M(+5.5%) |
| Feb 2017 | - | -$463.00 K(+16.0%) | -$1.45 M(+14.9%) |
| Nov 2016 | - | -$399.20 K(+22.6%) | -$1.26 M(-1.0%) |
| Aug 2016 | -$1.27 M(-34.7%) | -$325.60 K(+23.7%) | -$1.28 M(-18.5%) |
| May 2016 | - | -$263.20 K(-4.2%) | -$1.57 M(-13.7%) |
| Feb 2016 | - | -$274.60 K(-33.3%) | -$1.81 M(-9.2%) |
| Nov 2015 | - | -$411.70 K(-33.1%) | -$2.00 M(+2.3%) |
| Aug 2015 | -$1.95 M | -$615.60 K(+20.5%) | -$1.95 M(+4.6%) |
| May 2015 | - | -$511.00 K(+11.4%) | -$1.86 M(+3.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Feb 2015 | - | -$458.60 K(+25.1%) | -$1.80 M(+34.3%) |
| Nov 2014 | - | -$366.50 K(-30.7%) | -$1.34 M(-2.1%) |
| Aug 2014 | -$1.39 M(+288.0%) | - | - |
| July 2014 | - | -$528.90 K(+19.6%) | -$1.37 M(+60.1%) |
| Apr 2014 | - | -$442.30 K(+887.3%) | -$853.30 K(+108.9%) |
| Jan 2014 | - | -$44.80 K(-87.2%) | -$408.40 K(+13.7%) |
| Oct 2013 | -$359.20 K(+2484.2%) | -$350.20 K(+2088.8%) | -$359.20 K(-506.8%) |
| July 2013 | - | -$16.00 K(-715.4%) | $88.30 K(-61.8%) |
| Apr 2013 | - | $2600.00(-40.9%) | $231.20 K(+309.9%) |
| Jan 2013 | - | $4400.00(-95.5%) | $56.40 K(-508.7%) |
| Oct 2012 | -$13.90 K(-94.6%) | $97.30 K(-23.3%) | -$13.80 K(+253.8%) |
| July 2012 | - | $126.90 K(-173.7%) | -$3900.00(-98.8%) |
| Apr 2012 | - | -$172.20 K(+161.7%) | -$326.20 K(+29.5%) |
| Jan 2012 | - | -$65.80 K(-161.4%) | -$251.90 K(-2.9%) |
| Oct 2011 | -$259.50 K(-32.6%) | $107.20 K(-154.9%) | -$259.40 K(-35.3%) |
| July 2011 | - | -$195.40 K(+99.6%) | -$400.80 K(+109.2%) |
| Apr 2011 | - | -$97.90 K(+33.6%) | -$191.60 K(-10.8%) |
| Jan 2011 | - | -$73.30 K(+114.3%) | -$214.70 K(-44.2%) |
| Oct 2010 | -$385.10 K(-35.1%) | -$34.20 K(-347.8%) | -$385.10 K(-20.1%) |
| July 2010 | - | $13.80 K(-111.4%) | -$481.70 K(-27.2%) |
| Apr 2010 | - | -$121.00 K(-50.3%) | -$662.00 K(-7.4%) |
| Jan 2010 | - | -$243.70 K(+86.3%) | -$715.10 K(+20.5%) |
| Oct 2009 | -$593.50 K(+20.5%) | -$130.80 K(-21.4%) | -$593.50 K(-16.0%) |
| July 2009 | - | -$166.50 K(-4.4%) | -$706.40 K(+23.4%) |
| Apr 2009 | - | -$174.10 K(+42.6%) | -$572.30 K(+11.5%) |
| Jan 2009 | - | -$122.10 K(-49.9%) | -$513.50 K(+20.0%) |
| Oct 2008 | -$492.70 K(-53.1%) | -$243.70 K(+652.2%) | -$428.00 K(-181.2%) |
| July 2008 | - | -$32.40 K(-71.9%) | $527.30 K(-190.6%) |
| Apr 2008 | - | -$115.30 K(+215.0%) | -$582.20 K(-30.5%) |
| Jan 2008 | - | -$36.60 K(-105.1%) | -$837.60 K(-20.6%) |
| Oct 2007 | -$1.05 M(+396.5%) | $711.60 K(-162.3%) | -$1.06 M(-43.7%) |
| July 2007 | - | -$1.14 M(+208.0%) | -$1.87 M(+138.8%) |
| Apr 2007 | - | -$370.70 K(+45.9%) | -$784.90 K(+76.8%) |
| Jan 2007 | - | -$254.10 K(+135.9%) | -$444.00 K(+102.9%) |
| Oct 2006 | -$211.50 K(+502.6%) | -$107.70 K(+105.5%) | -$218.80 K(+96.9%) |
| July 2006 | - | -$52.40 K(+75.8%) | -$111.10 K(+89.3%) |
| Apr 2006 | - | -$29.80 K(+3.1%) | -$58.70 K(+103.1%) |
| Jan 2006 | - | -$28.90 K | -$28.90 K |
| Oct 2005 | -$35.10 K | - | - |
FAQ
- What is Lexaria Bioscience annual earnings before interest & taxes?
- What is the all time high annual EBIT for Lexaria Bioscience?
- What is Lexaria Bioscience annual EBIT year-on-year change?
- What is Lexaria Bioscience quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Lexaria Bioscience?
- What is Lexaria Bioscience quarterly EBIT year-on-year change?
- What is Lexaria Bioscience TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Lexaria Bioscience?
- What is Lexaria Bioscience TTM EBIT year-on-year change?
What is Lexaria Bioscience annual earnings before interest & taxes?
The current annual EBIT of LEXX is -$5.75 M
What is the all time high annual EBIT for Lexaria Bioscience?
Lexaria Bioscience all-time high annual earnings before interest & taxes is $442.70 K
What is Lexaria Bioscience annual EBIT year-on-year change?
Over the past year, LEXX annual earnings before interest & taxes has changed by +$780.87 K (+11.95%)
What is Lexaria Bioscience quarterly earnings before interest & taxes?
The current quarterly EBIT of LEXX is -$2.20 M
What is the all time high quarterly EBIT for Lexaria Bioscience?
Lexaria Bioscience all-time high quarterly earnings before interest & taxes is $711.60 K
What is Lexaria Bioscience quarterly EBIT year-on-year change?
Over the past year, LEXX quarterly earnings before interest & taxes has changed by -$1.06 M (-93.40%)
What is Lexaria Bioscience TTM earnings before interest & taxes?
The current TTM EBIT of LEXX is -$5.74 M
What is the all time high TTM EBIT for Lexaria Bioscience?
Lexaria Bioscience all-time high TTM earnings before interest & taxes is $527.30 K
What is Lexaria Bioscience TTM EBIT year-on-year change?
Over the past year, LEXX TTM earnings before interest & taxes has changed by +$239.94 K (+4.01%)